Not all sufferers with CLL have to have therapy. Even with all latest advancements, the iwCLL still endorses watchful observation for people with asymptomatic condition.86 This recommendation relies on not less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Supp… Read More